ARA290, a Peptide Derived from the Tertiary Structure of Erythropoietin, Produces Long-term Relief of Neuropathic Pain
Maarten Swartjes(Leiden University Medical Center), Albert Dahan(Centre for Human Drug Research), Michael Brines(Northwell Health), Aurora M. Morariu, Marieke Niesters(Leiden University Medical Center), Anthony Cerami(Araim Pharmaceuticals (United States)), Leon Aarts
Cited by 49
Related Papers
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
|Proceedings of the National Academy of Sciences|2000|1.4k
Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial
|Molecular Medicine|2002|1k
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
|Proceedings of the National Academy of Sciences|2001|1k
Decontamination of the Digestive Tract and Oropharynx in ICU Patients
|New England Journal of Medicine|2008|823